Capsulated Systems, Inc is extremely proud of the work our chemists and engineers have performed over the past four decades. They have been involved in microencapsulation of both inorganic and organic materials that have resulted in numerous patents. CSI holds 14 domestic and foreign patents including but not limited to the following US patents:

 

  • 6004417 - Method of Coupling Conduits using Microencapsulatable Solvents Adhesive Composition with Lamson & Sessions


  • 5922798 - Microencapsulatable Solvent Adhesive Composition with Lamson & Sessions


  • 5877236 - Microencapsulatable Solvent Adhesive Composition with Lamson & Sessions


  • 5824724 - Microencapsulatable Solvent Adhesive Composition with Lamson & Sessions


  • 5821293 - Microencapsulatable Solvent Adhesive Composition with Lamson & Sessions


  • 4536524 - Microencapsulated Epoxy Adhesive System


  • 4377621 - Hydrolyzed Ethylene Vinyl Acetate Encapsulating Coating


  • 4107071 - Method of Producing Microcapsules and Resulting Products

    In addition, CSI has spent the last ten years developing a long term post-operative local anesthetic called Lextrel for which patents have been applied in the US,  Europe and Canada.  Extensive in vitro and in vivo testing has been successfully completed with  Cornell University's College of Veterinary Medicine. Upon issuance of patents. this project and patents will be assigned to a new company.


    CSI also developed technology in over 1,000 Canon Patents on Microencapsulated Toner

    		•